The stock market showed continued strength on Thursday and the start of the third-quarter with the broader market hitting a fresh record high. Better-than-expected economic news and the approval of a $715 billion transportation package fueled sentiment. Initial jobless claims posted another post-pandemic low after falling 51,000 to 364,000 versus forecasts for a print of....

....

The stock market rebounded on Wednesday with the small-caps leading the charge higher and the blue-chips struggling. Some of the strength came after a few Federal Reserve officials helped ease worries about higher inflation.A dip in bond yields continues to be positive for Technology as the 10-year Treasury note is pushing two-week lows. Key....

Oversold, OCGN is gaining momentum. According to Tip Ranks, “Ocugen has inked a deal with India-based Bharat Biotech for the US rights for the company’s vaccine COVAXIN. And Bharat has now reported positive second interim analysis results from the COVAXIN Phase 3 trials. The vaccine displayed an overall efficacy rate of 78%, with 100%....

The stock market rebounded on Wednesday with the small-caps leading the charge higher and the blue-chips struggling. Some of the strength came after a few Federal Reserve officials helped ease worries about higher inflation.A dip in bond yields continues to be positive for Technology as the 10-year Treasury note is pushing two-week lows. Key....

....

The stock market traded on both sides of the ledger on Tuesday following a disappointing update on new home sales which declined 5.9% to a 863,000 rate in April. Other housing news was mostly positive as the FHFA home price index rose 1.4% to 324.9 while the S&P Case-Shiller 20-city home price index gained....

Oversold, OCGN is gaining momentum. According to Tip Ranks, “Ocugen has inked a deal with India-based Bharat Biotech for the US rights for the company’s vaccine COVAXIN. And Bharat has now reported positive second interim analysis results from the COVAXIN Phase 3 trials. The vaccine displayed an overall efficacy rate of 78%, with 100%....

The stock market was mixed on Wednesday after Treasury Secretary Janet Yellen attempted to walk back her comments where she said interest rates may need to rise to keep the economy from overheating. Yellen clarified that she was not making a forecast or advocating for a rate hike from the Fed.The blue-chips rebounded to....

....